Mohammad Albanna, PhD
CEO & Founder, Humabiologics, Inc
Dr. Albanna is the founder and CEO of Humabiologics, one of the only regenerative medicine companies focused on developing and commercializing human-derived biomaterials to researchers around the world for regenerative medicine applications. He holds a PhD in Biomedical Engineering, 2 master’s degrees in Materials Sciences and Electrical & Computer Engineering and completed a postdoctoral fellowship at Wake Forest Institute of Regenerative Medicine, where he served as the lead of the skin bioprinting group and is currently an adjunct assistant professor of Surgery at Atrium Health Wake Forest Baptist. Dr. Albanna authored several peer-reviewed papers, book chapters and is the inventor of several issued and patent-pending applications. Dr. Albanna has 15 years of industry experience, during which he has held several senior and executive leadership positions across several industries including medical devices, blood banking, and tissue banking. His work in regenerative medicine was recognized through several prestigious awards including the 2013 Thomas Edison Gold Award in Innovation, 2018 Arizona Innovator of the year finalist, and 2021 Arizona Leader in Innovation Award.